healthOme
Huntsville, US · Founded 2021 · Delaware corporation
HealthŌme combines insurance with health navigation services to improve how patients access, finance, and receive precision healthcare.
Founders & leadership
DS
David StertzerExecutive
CM
Camilo MoncadainExecutive
TK
Terri KinlochExecutive
KS
Kimberly ScottExecutive
Board
ST
Spencer TallBoard director
BC
Brittany ClementsBoard director
AM
Anne Melissa DowlingBoard director
Reported raises · per SEC filings
Form D private placements$9.9M disclosed across 2 rounds · 2023–2024
▶$2MraisedDec 2024 · 2 investors · OtherRule 506(b)
▶$2MraisedDec 2024 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- David StertzerExecutive Officer, Director
- Brittany ClementsDirector
- Spencer TallDirector
- Anne Melissa DowlingDirector
- Camilo MoncadaExecutive Officer
- Terri KinlochExecutive Officer
- Kimberly ScottExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Proceeds to insiders
- $925K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$7.9MraisedMay 2024 · 10 investors · OtherRule 506(b)
▶$7.9MraisedMay 2024 · 10 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Spencer TallDirector
- Brittany ClementsDirector
- Terri KinlochExecutive Officer
- Anne Melissa DowlingDirector
- Camilo MoncadaExecutive Officer
- David StertzerExecutive Officer, Director
- Kimberly ScottExecutive Officer
- Offering amount
- $8.4M
- Amount sold
- $7.9M
- Minimum investment
- $100K
- Proceeds to insiders
- $925K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 10
by search overlap
Myome22 shared keywordsMyOme provides genomic insights and clinical genetic screening reports to help individuals and healthcare providers assess risks for hereditary conditions and make informed health decisions.
Immunome21 shared keywordsImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.
OneOme20 shared keywordsOneOme is a precision medicine company that provides pharmacogenomics testing and analytics to healthcare providers, helping them optimize medication selection based on patients' genetic profiles. Co-founded by Mayo Clinic, the company serves healthcare teams and institutions globally seeking to improve patient outcomes and reduce costs through personalized medication decisions.
Alterome Therapeutics, Inc.19 shared keywordsAlterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic. It focuses on hard-to-drug cancer targets such as mutant KRAS and mutant AKT E17K across malignancies including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancers.
Noveome Biotherapeutics18 shared keywordsNoveome is a clinical-stage biopharmaceutical company developing ST266, a multi-targeted secretome containing hundreds of biologically active proteins designed for neuroprotection, inflammation modulation, and tissue healing. The company is investigating ST266's potential across ophthalmology, neurology, dermatology, and other therapeutic areas.
Freenome16 shared keywordsFreenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
Nucleome13 shared keywordsNucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.
Sensome11 shared keywordsSensome develops medical technology solutions at the intersection of engineering and life sciences, focusing on healthcare applications.
Cellanome10 shared keywordsCellanome develops a live-cell analysis platform using CellCage technology to create controlled microenvironments that enable researchers to observe cell behavior and molecular changes over time. The platform generates structured multimodal data for life sciences researchers and biopharma companies focused on oncology, neuroscience, immunology, and aging research.
Etiome10 shared keywordsEtiome develops stage-specific medicines by applying single-cell omics and artificial intelligence to map disease progression and identify disease-modifying targets at early biological inflection points for preemptive intervention. Founded in 2021 out of Flagship Pioneering's Preemptive Health and Medicine initiative, the biotech company focuses on treating or reversing disease before it advances to later stages.
Companies competing with healthOme for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does healthOme do?
- HealthŌme combines insurance with health navigation services to improve how patients access, finance, and receive precision healthcare.
- How much funding has healthOme raised?
- healthOme has disclosed $9.9M raised across 2 rounds.
- Where is healthOme headquartered?
- healthOme is headquartered in Huntsville, US.